XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total United Natural Foods, Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Noncontrolling Interests
Beginning balance (in shares) at Jul. 31, 2021     57.0 0.6        
Beginning balance at Jul. 31, 2021 $ 1,514 $ 1,515 $ 1 $ (24) $ 599 $ (39) $ 978 $ (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     2.0          
Restricted stock vestings (42) (42)     (42)      
Share-based compensation 33 33     33      
Other comprehensive income (loss) 61 61       61    
Distributions to noncontrolling interests (4)             (4)
Proceeds from issuance of common stock, net 9 9     9      
Net income 213 209         209 4
Ending balance (in shares) at Apr. 30, 2022     59.0 0.6        
Ending balance at Apr. 30, 2022 1,784 1,785 $ 1 $ (24) 599 22 1,187 (1)
Beginning balance (in shares) at Jan. 29, 2022     58.8 0.6        
Beginning balance at Jan. 29, 2022 1,683 1,684 $ 1 $ (24) 596 (9) 1,120 (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     0.2          
Restricted stock vestings (7) (7)     (7)      
Share-based compensation 10 10     10      
Other comprehensive income (loss) 31 31       31    
Distributions to noncontrolling interests (1)             (1)
Net income 68 67         67 1
Ending balance (in shares) at Apr. 30, 2022     59.0 0.6        
Ending balance at Apr. 30, 2022 $ 1,784 1,785 $ 1 $ (24) 599 22 1,187 (1)
Beginning balance (in shares) at Jul. 30, 2022 58.3   58.9 0.6        
Beginning balance at Jul. 30, 2022 $ 1,792 1,791 $ 1 $ (24) 608 (20) 1,226 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     2.0          
Restricted stock vestings (39) (39)     (39)      
Share-based compensation 33 33     33      
Repurchases of common stock (in shares)       1.1        
Repurchases of common stock (41) (41)   $ (41)        
Other comprehensive income (loss) 5 5       5    
Distributions to noncontrolling interests (5)             (5)
Net income $ 97 92         92 5
Ending balance (in shares) at Apr. 29, 2023 59.2   60.9 1.7        
Ending balance at Apr. 29, 2023 $ 1,842 1,841 $ 1 $ (65) 602 (15) 1,318 1
Beginning balance (in shares) at Jan. 28, 2023     60.9 1.3        
Beginning balance at Jan. 28, 2023 1,845 1,842 $ 1 $ (53) 592 (9) 1,311 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 10 10     10      
Repurchases of common stock (in shares)       0.4        
Repurchases of common stock (12) (12)   $ (12)        
Other comprehensive income (loss) (6) (6)       (6)    
Distributions to noncontrolling interests (3)             (3)
Net income $ 8 7         7 1
Ending balance (in shares) at Apr. 29, 2023 59.2   60.9 1.7        
Ending balance at Apr. 29, 2023 $ 1,842 $ 1,841 $ 1 $ (65) $ 602 $ (15) $ 1,318 $ 1